Isolated Echinococcus granulosus hydatid cyst in the CNS with severe reaction to treatment
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Hagemann et al.1 presented a case of cerebral Echinococcus granulosus with a severe meningeal inflammatory reaction caused by praziquantel (PZQ) and albendazole treatment who eventually recovered. The authors suggested that concomitant corticosteroid therapy, as used in neurocysticercosis, might minimize a severe reaction. We wish to report a fatal outcome in a patient with neurocysticercosis who was treated with PZQ and corticosteroid.
A 66-year-old man was hospitalized with several days of head ache and confusion. Examination showed an alert, dysarthric man, without neck stiffness or papilledema. A nonenhanced CT scan of the head was unremarkable, without calcifications or cysts. Contrast enhanced CT revealed multiple focal-enhancing lesions (figure) with mild edema. Magnetic resonance imaging of the head with gadolinium was reported as most consistent with cysticercosis. A lumbar puncture showed an opening pressure of 180 mm Hg. There were 90 leukocytes, with a differential of 45% neutrophils, 40% lymphocytes, and 1% eosinophils. The protein was elevated at 90 mg/dL, with a normal glucose of 29 mg/dL. Cysticercosis serology (immunoblot) was positive from the spinal fluid.
Dexamethasone, 2 mg twice daily, was started. The next day, PZQ was started at a dose of 50 mg/kg/day (1.5 gm tid). Three days after the start of PZQ, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Five New Things
NeurocysticercosisFive new thingsArturo Carpio, Agnès Fleury, W. Allen Hauser et al.Neurology: Clinical Practice, April 15, 2013 -
Views and Reviews
A diagnostic and therapeutic scheme for a solitary cysticercus granulomaG. Singh, V. Rajshekhar, J.M.K. Murthy et al.Neurology, December 13, 2010 -
Articles
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosisArturo Carpio, W. Allen Hauser et al.Neurology, December 10, 2002 -
Views & Reviews
Treatment of neurocysticercosisCurrent status and future research needsT. E. Nash, G. Singh, A. C. White et al.Neurology, October 09, 2006